Spirogen Ltd. and Bioatla Present Positive Data on Next-Generation Warheads in ADCS Against Cancer
4/8/2013 11:49:06 AM
More...
|
Ablynx and Spirogen Ltd. Enter Into a Research Collaboration to Evaluate the Potential of Novel Toxin-Nanobody Drug Conjugates in Cancer
2/25/2013 9:57:26 AM
More...
|
PolyTherics and Spirogen Ltd. Announce a Research Collaboration to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012 10:25:04 AM
More...
|
PolyTherics Announces a Research Collaboration With Spirogen Ltd. to Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer
4/2/2012 9:35:55 AM
More...
|
Spirogen Ltd. Announces a Research Collaboration and License Agreement with Spirogen Ltd. for the Discovery and Development of Antibody Drug Conjugates
1/6/2011 11:02:01 AM
More...
|